Sun Nov 17 09:00:12 UTC 2024: ## NHS Rolls Out Free Antismoking Pill to Tackle Smoking-Related Illnesses and Save Millions

**London, UK** – The UK’s National Health Service (NHS) is launching a nationwide program providing free varenicline, an antismoking pill, to approximately 85,000 smokers. This initiative aims to significantly reduce the burden of tobacco-related illnesses on the NHS, estimated to cost £2.5 billion annually.

Varenicline, a generic version of the previously withdrawn Champix, is a nicotine receptor agonist proven more effective than traditional nicotine replacement therapies. It works by reducing nicotine’s effects on the brain, lessening cravings and withdrawal symptoms. The medication will be provided alongside behavioral support programs to maximize its impact.

The rollout is part of a broader strategy to decrease smoking rates and achieve substantial cost savings. Research suggests the pill could prevent 9,500 smoking-related deaths over the next five years, saving taxpayers over £500 million annually. A previous study showed that for every pound spent on Champix (the branded version), £1.65 was saved on treating smoking-related illnesses.

Health Secretary Wes Streeting emphasized the preventative benefits, stating, “Prevention is better than cure. The rollout of this pill can save the NHS millions of pounds, save appointments to help other patients be seen faster, and save lives.”

The initiative complements the recently introduced Tobacco and Vapes Bill, which will gradually raise the legal smoking age, creating a “smoke-free generation.” While the government dropped plans to ban smoking in pub gardens, it’s considering restrictions in children’s playgrounds and outside schools and hospitals.

Despite varying success rates in clinical trials (14-50%), varenicline remains a leading smoking cessation aid, outperforming nicotine patches and gum. The drug is already approved in 116 countries and has been prescribed to over 24 million smokers globally. The NHS recommends taking varenicline for 12-24 weeks, alongside counselling and education. Potential side effects are listed on the NHS website. The program’s success will be closely monitored as part of the UK’s ongoing efforts to tackle the significant health and economic consequences of smoking.

Read More